Palvella Therapeutics Inc (PVLA) Stock Price, Quote, News & History

PVLANASDAQ
$138.16
-7.91-5.42%
At close: Sep 25, 5:00 PM EST
$138.16
N/A
After Hours: Sep 25, 4:00 PM EST

Palvella Therapeutics (PVLA) Stock Price, Quote, News & History | Benzinga

Financials

Quarterly
Annual
Name
Revenue
Change
Gross
Change
EBITDA
Change
EBIT
Change
Earnings
Change

Cash Flows

Operating Cash Flow (TTM)
-36.51M
Investing Cash Flow (TTM)
-
Financing Cash Flow (TTM)
216.20M
Free Cash Flow (TTM)
-36.51M
Capital Expenditure (TTM)
-
Net Change in Cash (TTM)
117.22M

Analyst Trends and Forecast

1
Mar
3
May
1
Sep
Buy
Hold
Sell
Strong Sell

Analyst Rating and Forecast

12345
4.0
Buy
Strong Buy
Buy
Hold
Sell
Strong Sell

Valuation Metrics

Enterprise Value
$1.74B
PE Ratio (TTM)
-
PE Ratio (FWD)
-
PEG Ratio (TTM)
-
PS Ratio (TTM)
-
PB Ratio (TTM)
9.70
Earnings Yield % (TTM)
-3.32%
Earnings Yield % (FWD)
-5.09%
EV / EBITDA (TTM)
-
Price / EBITDA (TTM)
-
Price / Free Cash Flow (TTM)
-
Book Value / Share
$15.05

Company Debt

Total Debt
-
LT Debt
-
LT Debt Issuance (TTM)
-
LT Debt Repayment (TTM)
-
Total Cash
$187.80M
Debt to Equity
0.00
Issuance of Debt (TTM)
-
Repayment of Debt (TTM)
-

Key Statistics

Open
$147.02
Close
$138.16
Volume / Avg.
193.34K / 234.51K
Day Range
$137.86 - $147.44
52 Wk Range
56.55 - 161.38
Market Cap
$1.99B
P/E Ratio
-
Dividend Yield
-
Exchange
NASDAQ
RSI
37
Short Interest
18.26%
Days to Cover
12.82

About

Sector
Health Care
Industry
Biotechnology
Palvella Therapeutics Inc is a clinical-stage biopharmaceutical company whose vision is to become the rare disease biopharmaceutical company focused on developing and commercializing novel therapies to treat patients suffering from serious, rare skin...
Show More
Edge Rankings

Stock Score Locked: Want to See it?

Benzinga Rankings give you vital metrics on any stock – anytime.

Reveal Full Score

FAQ

Q

How do I buy Palvella Therapeutics (PVLA) stock?

A

You can purchase shares of Palvella Therapeutics (NASDAQ:PVLA) through any online brokerage.

View our list of the best stock brokerages

Q

Who are Palvella Therapeutics (PVLA) competitors?

Q

What is the forecast, or price target, for Palvella Therapeutics (PVLA) stock?

A

Palvella Therapeutics has a consensus price target of $164.89.

Q

What is the current price for Palvella Therapeutics (PVLA)?

A

The stock price for Palvella Therapeutics (NASDAQ: PVLA) is $138.16 last updated September 25, 2026 at 4:00 PM EDT.

Q

Does Palvella Therapeutics (PVLA) pay a dividend?

A

There are no upcoming dividends for Palvella Therapeutics.

Q

When is Palvella Therapeutics (NASDAQ:PVLA) reporting earnings?

A

Palvella Therapeutics does not have any upcoming earnings scheduled.

Q

Is Palvella Therapeutics (PVLA) going to split?

A

There is no upcoming split for Palvella Therapeutics.

Q

What sector and industry does Palvella Therapeutics (PVLA) operate in?

A

Palvella Therapeutics is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.